Evidence map›Paper›PMID 27488917›Full record

SynthesisInternational journal of public health2016

Epidemiology and economic burden of measles, mumps, pertussis, and varicella in Germany: a systematic review.

Oliver Damm, Julian Witte, Stefanie Wetzka, Christine Prosser, Sebastian Braun, Robert Welte, Wolfgang Greiner

Abstract readSystematic Review
In one paragraph

Synthesis in International journal of public health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Close the gap for routine mumps vaccination in Japan.Human vaccines & immunotherapeutics · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Oliver DammDepartment of Health Economics and Health Care Management, School of Public Health, Bielefeld University, Universitätsstraße 25, 33615, Bielefeld, Germany. oliver.damm@uni-bielefeld.de.
Julian WitteDepartment of Health Economics and Health Care Management, School of Public Health, Bielefeld University, Universitätsstraße 25, 33615, Bielefeld, Germany.
Stefanie WetzkaGlaxoSmithKline Germany, Prinzregentenplatz 9, 81675, Munich, Germany.
Christine ProsserXcenda GmbH, Lange Laube 31, 30159, Hanover, Germany.
Sebastian BraunXcenda GmbH, Lange Laube 31, 30159, Hanover, Germany.
Robert WelteGlaxoSmithKline Germany, Prinzregentenplatz 9, 81675, Munich, Germany.
Wolfgang GreinerDepartment of Health Economics and Health Care Management, School of Public Health, Bielefeld University, Universitätsstraße 25, 33615, Bielefeld, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesDespite the availability of vaccines and the existence of public vaccination recommendations, outbreaks of vaccine-preventable childhood diseases still cause public health debate. The objective of this systematic review was to provide an overview of the current epidemiology and economic burden of measles, mumps, pertussis, and varicella in Germany.

methodsWe systematically reviewed studies published since 2000. The literature search was conducted using PubMed and EMBASE. Also, we used German notification data to give an up-to-date overview of the epidemiology of the four diseases under consideration.

resultsThirty-six studies were included in our review. Results suggest that there is still considerable morbidity due to childhood diseases in Germany. Studies providing cost estimates are scarce. Comparative analyses of different data sources (notification data vs. claims data) revealed a potential underestimation of incidence estimates when using notification data. Furthermore, several studies showed regional differences in incidence of some of the diseases under consideration.

conclusionsOur findings underline the need for improved vaccination and communication strategies targeting all susceptible age and risk groups on a national and local level.

Indexed as

ChickenpoxChickenpox VaccineGermanyHumansIncidenceMeaslesMeasles-Mumps-Rubella VaccineMumpsVaccines, CombinedVirus DiseasesWhooping CoughChickenpox VaccineMeasles-Mumps-Rubella VaccineVaccines, CombinedChildhood diseasesEconomic burdenEpidemiologyGermany

Identifiers

PMID27488917
PMCPMC5002040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.